Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer

Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer

BackgroundAlthough adjuvant chemotherapy is established for patients with non-small-cell lung cancer (NSCLC), the long-term survival remains to be improved. Postsurgical circulating tumor DNA (ctDNA) analysis of resectable NSCLC may identify patients at high risk of recurrence after adjuvant chemoth...

Full description

Bibliographic Details
Main Authors: Peng-Peng Kuang, Ning Li, Zui Liu, Tian-Yu Sun, Shu-Quan Wang, Jia Hu, Wei Ou, Si-Yu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
non-small-cell lung cancer
circulating tumor DNA
chemotherapy
recurrence
prognostic
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.595650/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.595650/full

Similar Items